AI-generated summary
The authors evaluated adding excimer laser to narrowband UVB phototherapy in 80 vitiligo patients whose response to NBUVB alone was slow or had stalled. The authors report that 54 patients responded after the combination, while 26 (32.5%) showed no remarkable change, and they suggest the combination may enhance response without remarkable side effects.
- Participants
- 80
- Who or what was studied
- Patients with vitiligo who had a slow response or no further improvement with narrowband UVB alone
- Limits stated in the abstract
- The abstract does not describe a control group, and the authors do not report formal statistical comparisons or follow-up duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Dose, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.